Skip to main content
. 2020 Jun 26;12(6):594. doi: 10.3390/pharmaceutics12060594

Scheme 2.

Scheme 2

Chemical structures of the used drugs for ocular release formulations. (a) Chloramphenicol (CHL), (b) Dexamethasone sodium phosphate (DexSP).